UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
D D D- D0 D1 D2 D5 D7 D8 D9 DA DB DC DD DE DF DG DH DI DJ DK DL DM DN DO DP DR DS DT DU DV DW DX DY
DO DOA DOB DOC DOD DOG DOL DOM DON DOO DOP DOQ DOR DOS DOT DOU DOW DOX
selected terms: 359 page 4 of 4

301. DOX/PRDL/VCR
(UMLS (NCI) C0281484) =Therapeutic or Preventive Procedure
331. Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine
(UMLS (NCI) C0879571) =Therapeutic or Preventive Procedure
302. DOX/PRED
(UMLS (NCI) C0279013) =Therapeutic or Preventive Procedure ;
332. Doxorubicin Hcl Liposome/Ifosfamide
(UMLS (NCI) C1134566) =Therapeutic or Preventive Procedure
303. DOX/PRED/VM-26
(UMLS (NCI) C0279511) =Therapeutic or Preventive Procedure
333. Doxorubicin Hcl Liposome/Interleukin-12
(UMLS (NCI) C0935798) =Therapeutic or Preventive Procedure
304. DOX/PRED/VP-16
(UMLS (NCI) C0279891) =Therapeutic or Preventive Procedure
334. Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine
(UMLS (NCI) C0879375) =Therapeutic or Preventive Procedure
305. DOX/progesterone
(UMLS (NCI) C0392995) =Therapeutic or Preventive Procedure
335. Doxorubicin HCl Liposome/Paclitaxel
(UMLS (NCI) C0678066) =Therapeutic or Preventive Procedure ;
306. DOX/PSC 833
(UMLS (NCI) C0392966) =Therapeutic or Preventive Procedure ;
336. Doxorubicin HCl Liposome/PSC 833
(UMLS (NCI) C0677968) =Therapeutic or Preventive Procedure
307. DOX/QND
(UMLS (NCI) C0280652) =Therapeutic or Preventive Procedure
337. Doxorubicin HCl Liposome/Topotecan
(UMLS (NCI) C0678077) =Therapeutic or Preventive Procedure ;
308. DOX/QND/VP-16
(UMLS (NCI) C0279040) =Therapeutic or Preventive Procedure
338. Doxorubicin HCl Liposome/Trastuzumab
(UMLS (NCI) C0879426) =Therapeutic or Preventive Procedure
309. DOX/SUR
(UMLS (NCI) C0280983) =Therapeutic or Preventive Procedure
339. Doxorubicin HCl Liposome/VX-853
(UMLS (NCI) C0677741) =Therapeutic or Preventive Procedure ;
310. DOX/SZC
(UMLS (NCI) C0281271) =Therapeutic or Preventive Procedure
340. Doxorubicin Hcl Liposome/ZD0473
(UMLS (NCI) C0935849) =Therapeutic or Preventive Procedure
311. DOX/TAX
(UMLS (NCI) C0280905) =Therapeutic or Preventive Procedure
341. Doxorubicin-HPMA
[A copolymer conjugate of the anthracycline antineoplastic antibiotic doxorubicin and the water-soluble polymer N-(2-hydroxypropyl) methacrylamide (HPMA). Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids. Conjugation with HPMA improves the therapeutic effects of doxorubicin, by promoting drug accumulation inside tumors, while decreasing systemic toxicity. ( NCI )] (UMLS (NCI) C0114882) =Organic Chemical; Pharmacologic Substance ;
312. DOX/TOPO
(UMLS (NCI) C0281396) =Therapeutic or Preventive Procedure ;
342. Doxorubicin/Etoposide/Ifosfamide/Vincristine
(UMLS (NCI) C0935877) =Therapeutic or Preventive Procedure ;
313. DOX/Trifluoperazine/VBL/VPAM
(UMLS (NCI) C0281142) =Therapeutic or Preventive Procedure
343. Doxorubicin/Etoposide/Mitotane/Tariquidar/Vincristine
(UMLS (NCI) C1328098) =Therapeutic or Preventive Procedure; ;
314. DOX/TSPA
(UMLS (NCI) C0280987) =Therapeutic or Preventive Procedure
344. Doxorubicin/Filgrastim/XR9576
(UMLS (NCI) C0935818) =Therapeutic or Preventive Procedure
315. DOX/TSPA/VBL
(UMLS (NCI) C0279686) =Therapeutic or Preventive Procedure
345. Doxorubicin/Hydrocortisone/Methotrexate
(UMLS (NCI) C0935715) =Therapeutic or Preventive Procedure
316. DOX/VBL
(UMLS (NCI) C0280930) =Therapeutic or Preventive Procedure
346. Doxorubicin/Imatinib Mesylate/Pegaspargase/Prednisone/Vincristine
(UMLS (NCI) C1328056) =Therapeutic or Preventive Procedure; ;
317. DOX/VBL/VP-16
(UMLS (NCI) C0255874) =Therapeutic or Preventive Procedure
347. Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine
(UMLS (NCI) C1327949) =Therapeutic or Preventive Procedure; ;
318. DOX/VCR/VP-16
(UMLS (NCI) C0078136) =Therapeutic or Preventive Procedure
348. Doxorubicin/Methotrexate/Pegaspargase/Vincristine
(UMLS (NCI) C0879560) =Therapeutic or Preventive Procedure
319. DOX/VCR/VX-710
(UMLS (NCI) C0796603) Doxorubicin/Vincristine/VX-710 =Therapeutic or Preventive Procedure
349. Doxorubicin/Motexafin Gadolinium
(UMLS (NCI) C1134645) =Therapeutic or Preventive Procedure
320. DOX/VNB
(UMLS (NCI) C0281256) =Therapeutic or Preventive Procedure ;
350. Doxorubicin/Oblimersen
(UMLS (NCI) C1327786) =Therapeutic or Preventive Procedure ;
321. DOX/VPAM
(UMLS (NCI) C0281009) =Therapeutic or Preventive Procedure
351. Doxorubicin/Octreotide
(UMLS (NCI) C0935743) =Therapeutic or Preventive Procedure
322. DOX/VX-710
(UMLS (NCI) C0338355) =Therapeutic or Preventive Procedure ;
352. Doxorubicin/Ranpirnase
(UMLS (NCI) C0879256) =Therapeutic or Preventive Procedure
323. Doxacurium Chloride
(UMLS (NCI) C0114872) =Organic Chemical; Pharmacologic Substance ;
=doxacurium;
=DOXACURIUM CHLORIDE 1 MG/ML
353. Doxorubicin/Strontium Chloride Sr 89
(UMLS (NCI) C1134484) =Therapeutic or Preventive Procedure
324. DOXAPRAM
[A respiratory stimulant with analeptic activity. Doxapram, independent of oxygen levels, directly stimulates the peripheral carotid chemoreceptors, possibly by inhibiting the potassium channels of type I cells within the carotid body, thereby stimulating catecholamines release. This results in the prevention or reversal of both narcotic- and CNS depressant-induced respiratory depression. ( NCI )] (UMLS (NCI) C0013084) =Organic Chemical; Pharmacologic Substance ;
=Pyrrolidinones;
[RE900] RESPIRATORY AGENTS, OTHER =1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate
354. Doxorubicin/SU5416
(UMLS (NCI) C0879494) =Therapeutic or Preventive Procedure
325. DOXAZOSIN
[A quinazoline with antihypertensive and antineoplastic properties. Doxazosin is an alpha-adrenergic antagonist that selectively inhibits alpha-1 adrenergic receptors. Blockages of the alpha-1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha-1c adrenoceptor, the predominant functional type in the prostate, which may partially attribute to its effect in treatment of benign prostatic hyperplasia. Furthermore, doxazosin induces apoptosis in prostate cancer cells mediated through inhibition of protein kinase B (PKB)/Akt-signaling death receptor regulatory pathway. ( NCI )] (UMLS (NCI) C0114873) =Organic Chemical; Pharmacologic Substance ;
=1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine;
[CV150] ALPHA-BLOCKERS/RELATED =DOXAZOSIN MESYLATE
355. Doxpicomine
(UMLS (NCI) C0058730) =Organic Chemical; Pharmacologic Substance
326. Doxefazepam
(UMLS (NCI) C0114875) =Organic Chemical; Pharmacologic Substance ;
356. doxycycline
[An antibiotic drug used to treat infection. ( NCI )] (UMLS (CSP) C0013090) =Organic Chemical; Antibiotic =[AM250] TETRACYCLINES;
=DOXYCYCLINE HYCLATE;
DOXYCYCLINE CALCIUM;
DOXYCYCLINE MONOHYDRATE
327. doxepin
[A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. ( MSH )] (UMLS (CSP) C0013085) =Organic Chemical; Pharmacologic Substance ;
=[CN601] TRICYCLIC ANTIDEPRESSANTS;
Dibenzoxepins;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=DOXEPIN HYDROCHLORIDE
357. DOXYCYCLINE HYCLATE
[The hyclate salt form of doxycycline, a synthetic, broad-spectrum tetracycline antibiotic exhibiting antimicrobial activity. Doxycycline hyclate binds reversibly to the 30S ribosomal subunit, possibly to the 50S ribosomal subunit as well, thereby blocking the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This leads to an inhibition of protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. ( NCI )] (UMLS (NCI) C0058731) =Organic Chemical; Antibiotic =doxycycline;
=DOXYCYCLINE CALCIUM;
DOXYCYCLINE MONOHYDRATE;
DOXYCYCLINE HYCLATE 100 MG;
DOXYCYCLINE HYCLATE 50 MG;
DOXYCYCLINE HYCLATE 200 MG;
DOXYCYCLINE HYCLATE 20 MG
328. doxil
[ ] (UMLS (CSP) C0279284) =Organic Chemical; Pharmacologic Substance
358. Doxycycline Hydrochloride
[The hydrochloride salt form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. (NCI) ( NCI )] (UMLS (NCI) C0771947) =Organic Chemical; Antibiotic ;
329. Doxorubicin HCl Liposome/Etoposide
(UMLS (NCI) C0678096) =Therapeutic or Preventive Procedure
359.
[use for measured amounts of chemicals. ( CSP )] (UMLS (NCI) C0178602) =Quantitative Concept =Pharmacologic;
=Overdose;
radiation therapy dosage;
drug administration rate/duration
330. Doxorubicin Hcl Liposome/Gemcitabine
(UMLS (NCI) C0879589) =Therapeutic or Preventive Procedure

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM